Reviews - 1yah mentioned but not cited (1)
- Biochemical and docking analysis of substrate interactions with polyisoprenylated methylated protein methyl esterase. Duverna R, Ablordeppey SY, Lamango NS. Curr Cancer Drug Targets 10 634-648 (2010)
Articles - 1yah mentioned but not cited (6)
- Polyisoprenylation potentiates the inhibition of polyisoprenylated methylated protein methyl esterase and the cell degenerative effects of sulfonyl fluorides. Aguilar B, Amissah F, Duverna R, Lamango NS. Curr Cancer Drug Targets 11 752-762 (2011)
- Polyisoprenylated methylated protein methyl esterase is both sensitive to curcumin and overexpressed in colorectal cancer: implications for chemoprevention and treatment. Amissah F, Duverna R, Aguilar BJ, Poku RA, Lamango NS. Biomed Res Int 2013 416534 (2013)
- Comparison of the Structure and Activity of Glycosylated and Aglycosylated Human Carboxylesterase 1. Arena de Souza V, Scott DJ, Nettleship JE, Rahman N, Charlton MH, Walsh MA, Owens RJ. PLoS One 10 e0143919 (2015)
- Inhibition of polyisoprenylated methylated protein methyl esterase by synthetic musks induces cell degeneration. Ayuk-Takem L, Amissah F, Aguilar BJ, Lamango NS. Environ Toxicol 29 466-477 (2014)
- In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics. Yin L, Zheng L, Xu L, Dong D, Han X, Qi Y, Zhao Y, Xu Y, Peng J. BMC Complement Altern Med 15 41 (2015)
- Combined Ensemble Docking and Machine Learning in Identification of Therapeutic Agents with Potential Inhibitory Effect on Human CES1. Briand E, Thomsen R, Linnet K, Rasmussen HB, Brunak S, Taboureau O. Molecules 24 E2747 (2019)
Reviews citing this publication (10)
- Structure, function and regulation of carboxylesterases. Satoh T, Hosokawa M. Chem Biol Interact 162 195-211 (2006)
- Human carboxylesterase isozymes: catalytic properties and rational drug design. Imai T. Drug Metab Pharmacokinet 21 173-185 (2006)
- Carboxylesterase inhibitors. Hatfield MJ, Potter PM. Expert Opin Ther Pat 21 1159-1171 (2011)
- Carboxylesterases: General detoxifying enzymes. Hatfield MJ, Umans RA, Hyatt JL, Edwards CC, Wierdl M, Tsurkan L, Taylor MR, Potter PM. Chem Biol Interact 259 327-331 (2016)
- The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics. Di L. Curr Drug Metab 20 91-102 (2019)
- Recent progress in the discovery of natural inhibitors against human carboxylesterases. Wang DD, Zou LW, Jin Q, Hou J, Ge GB, Yang L. Fitoterapia 117 84-95 (2017)
- Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics. Rasmussen HB, Bjerre D, Linnet K, Jürgens G, Dalhoff K, Stefansson H, Hankemeier T, Kaddurah-Daouk R, Taboureau O, Brunak S, Houmann T, Jeppesen P, Pagsberg AK, Plessen K, Dyrborg J, Hansen PR, Hansen PE, Hughes T, Werge T, INDICES Consortium. Pharmacogenomics 16 649-665 (2015)
- Strategies for Glycoengineering Therapeutic Proteins. Dammen-Brower K, Epler P, Zhu S, Bernstein ZJ, Stabach PR, Braddock DT, Spangler JB, Yarema KJ. Front Chem 10 863118 (2022)
- Regulations of Xenobiotics and Endobiotics on Carboxylesterases: A Comprehensive Review. Xu Y, Zhang C, He W, Liu D. Eur J Drug Metab Pharmacokinet 41 321-330 (2016)
- Human carboxylesterases and fluorescent probes to image their activity in live cells. Singh A, Gao M, Beck MW. RSC Med Chem 12 1142-1153 (2021)
Articles citing this publication (62)
- PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach. Liu X, Ouyang S, Yu B, Liu Y, Huang K, Gong J, Zheng S, Li Z, Li H, Jiang H. Nucleic Acids Res 38 W609-14 (2010)
- Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis. Zhu HJ, Patrick KS, Yuan HJ, Wang JS, Donovan JL, DeVane CL, Malcolm R, Johnson JA, Youngblood GL, Sweet DH, Langaee TY, Markowitz JS. Am J Hum Genet 82 1241-1248 (2008)
- Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins. Holmes RS, Wright MW, Laulederkind SJ, Cox LA, Hosokawa M, Imai T, Ishibashi S, Lehner R, Miyazaki M, Perkins EJ, Potter PM, Redinbo MR, Robert J, Satoh T, Yamashita T, Yan B, Yokoi T, Zechner R, Maltais LJ. Mamm Genome 21 427-441 (2010)
- The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response. Lewis JP, Horenstein RB, Ryan K, O'Connell JR, Gibson Q, Mitchell BD, Tanner K, Chai S, Bliden KP, Tantry US, Peer CJ, Figg WD, Spencer SD, Pacanowski MA, Gurbel PA, Shuldiner AR. Pharmacogenet Genomics 23 1-8 (2013)
- Hydrolytic metabolism of pyrethroids by human and other mammalian carboxylesterases. Ross MK, Borazjani A, Edwards CC, Potter PM. Biochem Pharmacol 71 657-669 (2006)
- Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1. Bencharit S, Edwards CC, Morton CL, Howard-Williams EL, Kuhn P, Potter PM, Redinbo MR. J Mol Biol 363 201-214 (2006)
- Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2. Wang J, Williams ET, Bourgea J, Wong YN, Patten CJ. Drug Metab Dispos 39 1329-1333 (2011)
- In vitro evaluation of inhibitory effects of antidiabetic and antihyperlipidemic drugs on human carboxylesterase activities. Fukami T, Takahashi S, Nakagawa N, Maruichi T, Nakajima M, Yokoi T. Drug Metab Dispos 38 2173-2178 (2010)
- Crystal structures of human carboxylesterase 1 in covalent complexes with the chemical warfare agents soman and tabun. Fleming CD, Edwards CC, Kirby SD, Maxwell DM, Potter PM, Cerasoli DM, Redinbo MR. Biochemistry 46 5063-5071 (2007)
- Examination of the carboxylesterase phenotype in human liver. Ross MK, Borazjani A, Wang R, Crow JA, Xie S. Arch Biochem Biophys 522 44-56 (2012)
- Different inhibitory effects in rat and human carboxylesterases. Takahashi S, Katoh M, Saitoh T, Nakajima M, Yokoi T. Drug Metab Dispos 37 956-961 (2009)
- Biochemical and molecular analysis of carboxylesterase-mediated hydrolysis of cocaine and heroin. Hatfield MJ, Tsurkan L, Hyatt JL, Yu X, Edwards CC, Hicks LD, Wadkins RM, Potter PM. Br J Pharmacol 160 1916-1928 (2010)
- Residue-centric modeling and design of saccharide and glycoconjugate structures. Labonte JW, Adolf-Bryfogle J, Schief WR, Gray JJ. J Comput Chem 38 276-287 (2017)
- Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenation. Eyler RF, Heung M, Pleva M, Sowinski KM, Park PK, Napolitano LM, Mueller BA. Pharmacotherapy 32 1061-1069 (2012)
- Analysis of mammalian carboxylesterase inhibition by trifluoromethylketone-containing compounds. Wadkins RM, Hyatt JL, Edwards CC, Tsurkan L, Redinbo MR, Wheelock CE, Jones PD, Hammock BD, Potter PM. Mol Pharmacol 71 713-723 (2007)
- Liver prenylated methylated protein methyl esterase is the same enzyme as Sus scrofa carboxylesterase. Oboh OT, Lamango NS. J Biochem Mol Toxicol 22 51-62 (2008)
- Allosteric kinetics of human carboxylesterase 1: species differences and interindividual variability. Takahashi S, Katoh M, Saitoh T, Nakajima M, Yokoi T. J Pharm Sci 97 5434-5445 (2008)
- In silico prediction of human carboxylesterase-1 (hCES1) metabolism combining docking analyses and MD simulations. Vistoli G, Pedretti A, Mazzolari A, Testa B. Bioorg Med Chem 18 320-329 (2010)
- Prediction and in vitro evaluation of selected protease inhibitor antiviral drugs as inhibitors of carboxylesterase 1: a potential source of drug-drug interactions. Rhoades JA, Peterson YK, Zhu HJ, Appel DI, Peloquin CA, Markowitz JS. Pharm Res 29 972-982 (2012)
- Carboxylesterase 1 Is Regulated by Hepatocyte Nuclear Factor 4α and Protects Against Alcohol- and MCD diet-induced Liver Injury. Xu J, Xu Y, Li Y, Jadhav K, You M, Yin L, Zhang Y. Sci Rep 6 24277 (2016)
- Mammalian carboxylesterase 3: comparative genomics and proteomics. Holmes RS, Cox LA, VandeBerg JL. Genetica 138 695-708 (2010)
- RNA interference revealed the roles of two carboxylesterase genes in insecticide detoxification in Locusta migratoria. Zhang J, Li D, Ge P, Yang M, Guo Y, Zhu KY, Ma E, Zhang J. Chemosphere 93 1207-1215 (2013)
- Crystal structure of the Geobacillus stearothermophilus carboxylesterase Est55 and its activation of prodrug CPT-11. Liu P, Ewis HE, Tai PC, Lu CD, Weber IT. J Mol Biol 367 212-223 (2007)
- Opossum carboxylesterases: sequences, phylogeny and evidence for CES gene duplication events predating the marsupial-eutherian common ancestor. Holmes RS, Chan J, Cox LA, Murphy WJ, VandeBerg JL. BMC Evol Biol 8 54 (2008)
- Comparison of benzil and trifluoromethyl ketone (TFK)-mediated carboxylesterase inhibition using classical and 3D-quantitative structure-activity relationship analysis. Harada T, Nakagawa Y, Wadkins RM, Potter PM, Wheelock CE. Bioorg Med Chem 17 149-164 (2009)
- iDrug: a web-accessible and interactive drug discovery and design platform. Wang X, Chen H, Yang F, Gong J, Li S, Pei J, Liu X, Jiang H, Lai L, Li H. J Cheminform 6 28 (2014)
- Molecular and functional characterization of cDNAs putatively encoding carboxylesterases from the migratory locust, Locusta migratoria. Zhang J, Li D, Ge P, Guo Y, Zhu KY, Ma E, Zhang J. PLoS One 9 e94809 (2014)
- Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-diones. Parkinson EI, Jason Hatfield M, Tsurkan L, Hyatt JL, Edwards CC, Hicks LD, Yan B, Potter PM. Bioorg Med Chem 19 4635-4643 (2011)
- Automated carboxylesterase assay for the evaluation of ionic liquids' human toxicity. Cunha E, Pinto PC, Carvalho JP, Saraiva ML. J Hazard Mater 244-245 563-569 (2013)
- Automated evaluation of pharmaceutically active ionic liquids' (eco)toxicity through the inhibition of human carboxylesterase and Vibrio fischeri. Costa SP, Justina VD, Bica K, Vasiloiu M, Pinto PC, Saraiva ML. J Hazard Mater 265 133-141 (2014)
- Baboon carboxylesterases 1 and 2: sequences, structures and phylogenetic relationships with human and other primate carboxylesterases. Holmes RS, Glenn JP, VandeBerg JL, Cox LA. J Med Primatol 38 27-38 (2009)
- Functional characterization of carboxylesterase gene mutations involved in Aphis gossypii resistance to organophosphate insecticides. Gong YH, Ai GM, Li M, Shi XY, Diao QY, Gao XW. Insect Mol Biol 26 702-714 (2017)
- Mammalian carboxylesterase 5: comparative biochemistry and genomics. Holmes RS, Cox LA, Vandeberg JL. Comp Biochem Physiol Part D Genomics Proteomics 3 195-204 (2008)
- Multiple cytochrome P450 isoforms are involved in the generation of a pharmacologically active thiol metabolite, whereas paraoxonase 1 and carboxylesterase 1 catalyze the formation of a thiol metabolite isomer from ticlopidine. Kim MJ, Jeong ES, Park JS, Lee SJ, Ghim JL, Choi CS, Shin JG, Kim DH. Drug Metab Dispos 42 141-152 (2014)
- A new class of mammalian carboxylesterase CES6. Holmes RS, Cox LA, Vandeberg JL. Comp Biochem Physiol Part D Genomics Proteomics 4 209-217 (2009)
- Glycoengineering of Esterase Activity through Metabolic Flux-Based Modulation of Sialic Acid. Mathew MP, Tan E, Labonte JW, Shah S, Saeui CT, Liu L, Bhattacharya R, Bovonratwet P, Gray JJ, Yarema KJ. Chembiochem 18 1204-1215 (2017)
- Influence of ionization state on the activation of temocapril by hCES1: a molecular-dynamics study. Vistoli G, Pedretti A, Mazzolari A, Bolchi C, Testa B. Chem Biodivers 6 2092-2100 (2009)
- Reactivity versus steric effects in fluorinated ketones as esterase inhibitors: a quantum mechanical and molecular dynamics study. Rayo J, Muñoz L, Rosell G, Hammock BD, Guerrero A, Luque FJ, Pouplana R. J Mol Model 16 1753-1764 (2010)
- Substrate-Competitive Activity-Based Profiling of Ester Prodrug Activating Enzymes. Xu H, Majmudar JD, Davda D, Ghanakota P, Kim KH, Carlson HA, Showalter HD, Martin BR, Amidon GL. Mol Pharm 12 3399-3407 (2015)
- Accelerated evolution of CES7, a gene encoding a novel major urinary protein in the cat family. Li G, Janecka JE, Murphy WJ. Mol Biol Evol 28 911-920 (2011)
- Nuclear-lipid-droplet proteome: carboxylesterase as a nuclear lipase involved in lipid-droplet homeostasis. Lagrutta LC, Layerenza JP, Bronsoms S, Trejo SA, Ves-Losada A. Heliyon 7 e06539 (2021)
- Pharmacometabolomics Informs About Pharmacokinetic Profile of Methylphenidate. Kaddurah-Daouk R, Hankemeier T, Scholl EH, Baillie R, Harms A, Stage C, Dalhoff KP, Jűrgens G, Taboureau O, Nzabonimpa GS, Motsinger-Reif AA, Thomsen R, Linnet K, Rasmussen HB, INDICES Consortium, Pharmacometabolomics Research Network. CPT Pharmacometrics Syst Pharmacol 7 525-533 (2018)
- The novel nematicide wact-86 interacts with aldicarb to kill nematodes. Burns AR, Bagg R, Yeo M, Luciani GM, Schertzberg M, Fraser AG, Roy PJ. PLoS Negl Trop Dis 11 e0005502 (2017)
- Carboxylesterase 2 production and characterization in human cells: new insights into enzyme oligomerization and activity. Lamego J, Cunha B, Peixoto C, Sousa MF, Alves PM, Simplício AL, Coroadinha AS. Appl Microbiol Biotechnol 97 1161-1173 (2013)
- Horse carboxylesterases: evidence for six CES1 and four families of CES genes on chromosome 3. Holmes RS, Cox LA, Vandeberg JL. Comp Biochem Physiol Part D Genomics Proteomics 4 54-65 (2009)
- Influence of sulfur oxidation state and steric bulk upon trifluoromethyl ketone (TFK) binding kinetics to carboxylesterases and fatty acid amide hydrolase (FAAH). Wheelock CE, Nishi K, Ying A, Jones PD, Colvin ME, Olmstead MM, Hammock BD. Bioorg Med Chem 16 2114-2130 (2008)
- Inhibition of porcine liver carboxylesterase by phosphorylated flavonoids. Wei Y, Peng AY, Huang J. Chem Biol Interact 204 75-79 (2013)
- Structural characterization and function determination of a nonspecific carboxylate esterase from the amidohydrolase superfamily with a promiscuous ability to hydrolyze methylphosphonate esters. Xiang DF, Kumaran D, Swaminathan S, Raushel FM. Biochemistry 53 3476-3485 (2014)
- Immobilization of active human carboxylesterase 1 in biomimetic silica nanoparticles. Edwards JS, Kumbhar A, Roberts A, Hemmert AC, Edwards CC, Potter PM, Redinbo MR. Biotechnol Prog 27 863-869 (2011)
- A Space-Dependent 'Enzyme-Substrate' Type Probe based on 'Carboxylesterase-Amide Group' for Ultrafast Fluorescent Imaging Orthotopic Hepatocellular Carcinoma. Wen Y, Jing N, Zhang M, Huo F, Li Z, Yin C. Adv Sci (Weinh) 10 e2206681 (2023)
- Comparative chemical and biological hydrolytic stability of homologous esters and isosteres. de Souza HMR, Guedes JS, Freitas RHCN, Gelves LGV, Fokoue HH, Sant'Anna CMR, Barreiro EJ, Lima LM. J Enzyme Inhib Med Chem 37 718-727 (2022)
- In Silico Design and Evaluation of Carboxylesterase Inhibitors. Stoddard SV, Yu X, Potter PM, Wadkins RM. J Pest Sci (2004) 35 240-249 (2010)
- One-pot, two-step desymmetrization of symmetrical benzils catalyzed by the methylsulfinyl (dimsyl) anion. Ragno D, Bortolini O, Giovannini PP, Massi A, Pacifico S, Zaghi A. Org Biomol Chem 12 5733-5744 (2014)
- Reversible inhibitory effects of saturated and unsaturated alkyl esters on the carboxylesterases activity in rat intestine. Li P, Zhu CL, Zhang XX, Gan L, Yu HZ, Gan Y. Lipids 45 603-612 (2010)
- Bovine Carboxylesterases: Evidence for Two CES1 and Five Families of CES Genes on Chromosome 18. Holmes RS, Cox LA, Vandeberg JL. Comp Biochem Physiol Part D Genomics Proteomics 4 11-20 (2009)
- Cloning and molecular modeling of a thermostable carboxylesterase from the chicken uropygial glands. Fendri A, Frikha F, Louati H, Bou Ali M, Gargouri H, Gargouri Y, Miled N. J Mol Graph Model 56 1-9 (2015)
- Polyisoprenylated Cysteinyl Amide Inhibitors: A Novel Approach to Controlling Cancers with Hyperactive Growth Signaling. Lamango NS, Nkembo AT, Ntantie E, Tawfeeq N. Curr Med Chem 28 3476-3489 (2021)
- Simple and Label-Free Detection of Carboxylesterase and Its Inhibitors Using a Liquid Crystal Droplet Sensing Platform. Nguyen DK, Jang CH. Micromachines (Basel) 13 490 (2022)
- The Crystal Structure of Mouse Ces2c, a Potential Ortholog of Human CES2, Shows Structural Similarities in Substrate Regulation and Product Release to Human CES1. Eisner H, Riegler-Berket L, Gamez CFR, Sagmeister T, Chalhoub G, Darnhofer B, Jazleena PJ, Birner-Gruenberger R, Pavkov-Keller T, Haemmerle G, Schoiswohl G, Oberer M. Int J Mol Sci 23 13101 (2022)
- Carboxylesterase Activities and Protein Expression in Rabbit and Pig Ocular Tissues. Hammid A, Fallon JK, Lassila T, Salluce G, Smith PC, Tolonen A, Sauer A, Urtti A, Honkakoski P. Mol Pharm 18 1305-1316 (2021)
- Catalytic Hydrolysis Mechanism of Cocaine by Human Carboxylesterase 1: An Orthoester Intermediate Slows Down the Reaction. Yan M, Zhang Z, Liu Z, Zhang C, Zhang J, Fan S, Yang Z. Molecules 24 E4057 (2019)
- High-resolution structural-omics of human liver enzymes. Su CC, Lyu M, Zhang Z, Miyagi M, Huang W, Taylor DJ, Yu EW. Cell Rep 42 112609 (2023)